These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 2253250

  • 21. Hyperuricemia and gout: an update.
    Khachadurian AK.
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [Abstract] [Full Text] [Related]

  • 22. Familial nephropathy with hyperuricemia and gout.
    Leumann EP, Wegmann W.
    Nephron; 1983 Dec; 34(1):51-7. PubMed ID: 6855996
    [Abstract] [Full Text] [Related]

  • 23. Hyperuricemia and gout.
    Sloan RW.
    J Fam Pract; 1982 May; 14(5):923-6, 930-1, 934. PubMed ID: 7042900
    [Abstract] [Full Text] [Related]

  • 24. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D, Sripradit S, Angthararak S.
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA, Simmonds HA, North JD.
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract] [Full Text] [Related]

  • 28. Gout as a manifestation of familial juvenile hyperuricemic nephropathy.
    Spain H, Plumb T, Mikuls TR.
    J Clin Rheumatol; 2014 Dec; 20(8):442-4. PubMed ID: 25417683
    [Abstract] [Full Text] [Related]

  • 29. [Severity and incidence of skin reactions of intolerance to uric acid inhibitors in renal insufficiency].
    Branger B, Méry D, Mion C, Mirouze J.
    Ann Med Interne (Paris); 2014 Dec; 127(8-9):596-9. PubMed ID: 137686
    [No Abstract] [Full Text] [Related]

  • 30. Familial juvenile hyperuricemic nephropathy as rare cause of dialysis-dependent chronic kidney disease-a series of cases in two families.
    Kaminska-Pajak KA, Dyga K, Adamczyk P, Szczepańska M, Zaniew M, Beck B, Tkaczyk M.
    Ren Fail; 2016 Nov; 38(10):1759-1762. PubMed ID: 27764983
    [Abstract] [Full Text] [Related]

  • 31. [Combination of allopurinol and benziodarone in prolonged treatment of hyperuricemia due to chronic renal insufficiency].
    Bianchi Porro G, Petrillo M, Bianchessi M.
    Minerva Med; 1972 Mar 07; 63(17):1000-9. PubMed ID: 5016057
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Effect of allopurinol on the indicators of immunity in podagra and experimental hyperuricemia].
    Siniachenko OV, Nikolenko IuI, Diadyk AI, Bortnik VA, Okushko RV.
    Revmatologiia (Mosk); 1991 Mar 07; (1):12-5. PubMed ID: 2068454
    [Abstract] [Full Text] [Related]

  • 35. [Hyperuricemia, gout and gout-induced nephropathy].
    Arkhipov VE, Borisov IA, Nasonov EL, Sura VV.
    Ter Arkh; 1980 Mar 07; 52(4):133-42. PubMed ID: 6996182
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M, Hachicha J, Bahloul Z, Kaddour N, Kharrat M, Jarraya F, Jarraya A.
    Transplant Proc; 1995 Oct 07; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.